Bioventus Inc. (BVS)

Bioventus Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	434	686	332	162	861	-
Market Cap Growth	81.27%	106.84%	105.22%	-81.23%	-	-
Enterprise Value	777	1,086	775	605	1,054	-
Last Close Price	6.54	10.50	5.27	2.61	14.49	-
Forward PE	8.61	20.00	21.82	17.17	21.50	-
PS Ratio	0.75	1.20	0.65	0.32	2.00	-
PB Ratio	2.92	3.70	1.50	0.39	1.61	-
P/FCF Ratio	18.14	18.16	41.57	-	90.94	-
P/OCF Ratio	17.04	17.69	21.63	-	37.46	-
PEG Ratio	-	-	-	2.07	2.07	-
EV/Sales Ratio	1.37	1.90	1.51	1.18	2.45	-
EV/EBITDA Ratio	13.22	18.42	26.88	-	25.38	-
EV/EBIT Ratio	19.63	27.27	382.69	-	50.07	-
EV/FCF Ratio	32.49	28.75	97.14	-	111.28	-
Debt / Equity Ratio	1.97	1.92	1.90	1.06	0.71	1.42
Debt / EBITDA Ratio	5.69	5.50	11.81	719.64	8.23	3.83
Debt / FCF Ratio	15.30	9.42	52.70	-	39.72	3.70
Asset Turnover	0.76	0.75	0.47	0.39	0.50	0.66
Inventory Turnover	1.94	2.01	2.09	2.47	2.82	3.11
Quick Ratio	0.81	0.80	0.91	0.55	0.93	1.43
Current Ratio	1.43	1.31	1.53	0.90	1.46	1.73
Return on Equity (ROE)	-20.24%	-21.55%	-38.27%	-30.58%	3.38%	10.16%
Return on Assets (ROA)	3.33%	3.24%	0.12%	-1.67%	1.53%	2.82%
Return on Capital (ROIC)	4.18%	4.21%	0.17%	-2.46%	2.09%	3.84%
Return on Capital Employed (ROCE)	7.70%	7.70%	0.30%	-	2.00%	5.90%
Earnings Yield	-7.21%	-4.89%	-47.08%	-98.15%	2.25%	-
FCF Yield	5.51%	5.51%	2.40%	-15.50%	1.10%	-
Payout Ratio	-	-	-	-	-	121.18%
Buyback Yield / Dilution	-3.56%	-3.03%	-2.05%	-35.00%	-828.01%	-

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q